Remco G A Erkens
3PUBLICATIONS
7CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria.Remco G A Erkens, Greta Rogani, Laura Huber
|Jul 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants.Remco G A Erkens, Jorg J A Calis, Anouk Verwoerd
Pageof 1